An International Reproducibility Study Validating Quantitative Determination of ERBB2, ESR1, PGR, and MKI67 mRNA in Breast Cancer Using MammaTyper®

Breast Cancer Research - United Kingdom
doi 10.1186/s13058-017-0848-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Pre-Diagnostic Smoking Is Associated With Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2017English

AKT Signaling in ERBB2-amplified Breast Cancer

Pharmacology and Therapeutics
Pharmacology
2016English

ErbB2 Regulation of C-SRC Activity in Breast Cancer

2000English

Quantitative ER and PgR Assessment as Predictors of Benefit From Lapatinib in Postmenopausal Women With Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Pharmacoeconomic Study of Herceptin® (Trastuzumab) for Breast Cancer Patients

Pharmacoeconomics: theory and practice
2014English

Role of Integrin Alpha 5 in ErbB2-Mediated Breast Cancer

2009English

Association Between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 Polymorphisms and Breast Cancer in Jordan: A Case-Control Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Monitoring Neoadjuvant Chemotherapy in Breast Cancer Using Quantitative Diffuse Optical Spectroscopy: A Case Study

Journal of Biomedical Optics
ElectronicOpticsMolecular Physics,OpticalBiomaterialsAtomicMagnetic MaterialsBiomedical Engineering
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy